Pfizer heading for best month in 30 years amid covid: Chart

(Bloomberg) – The coronavirus pandemic and the emergence of the new omicron variant of Covid-19 have helped Pfizer Inc. – maker of one of the world’s best-selling vaccines – move into their strongest month. in 30 years. Stocks have risen almost 24% in November, the biggest rise since December 1991. In that year, the president of the United States was George HW Bush, Treasury bond yields were above 7.8%, AIDS was the The virus that caused fear in the population and the promising new drugs from Pfizer were Procardia, to treat angina pectoris, and Diflucan, to fight fungal infections.

Most Read from Bloomberg

Original Note:

Covid Woes Put Pfizer on Track for Best Month in 30 Years: Chart

Most Read from Bloomberg Businessweek

©2021 Bloomberg L.P.

Article Source